KAZIA RECOGNISES GBM AWARENESS DAY 2022 AS IT EXPANDS CLINICAL TRIAL ACTIVITY IN EUROPE AND US
KAZIA RECOGNISES GBM AWARENESS DAY 2022 AS IT EXPANDS CLINICAL TRIAL ACTIVITY IN EUROPE AND US
Stay updated with breaking news from Jane Lowe. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
KAZIA RECOGNISES GBM AWARENESS DAY 2022 AS IT EXPANDS CLINICAL TRIAL ACTIVITY IN EUROPE AND US
KAZIA RECOGNISES GBM AWARENESS DAY 2022 AS IT EXPANDS CLINICAL TRIAL ACTIVITY IN EUROPE AND US
Dr. Geoff Nichol, M.B., Ch.B., M.B.A., joins HaemaLogiX’s Board of Directors as Non-Executive Director, bringing nearly 30 years of global...
/PRNewswire/ -- HaemaLogiX Ltd, a clinical stage immuno-oncology biotech developing novel immunotherapies for patients with blood cancers, is pleased to...
/PRNewswire/ -- HaemaLogiX Ltd, a clinical stage immuno-oncology biotech developing novel immunotherapies for patients with blood cancers, is pleased to...